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A 16-year-old boy presented with an unusual case of a supratentorial, extraaxial small 
round blue cell tumor of the central nervous system, which was most likely a primitive 
neuroectodermal tumor (PNET). Preoperative computed tomography and magnetic 
resonance imaging showed a large multistage hematoma in the left central region. 
Intraoperatively, a small, superficial tumorous lesion was found between the sagittal 
sinus and a large cortical vein hidden by the hematoma. The histological diagnosis was 
PNET. This tumor is one of the most aggressive intracerebral tumors, not only in 
children, so treatment strategies must be early, profound, and interdisciplinary. This 
case represents an important example of atypical extraaxial appearance of this lesion, 
which should be considered in the differential diagnosis of cortical or subcortical 
hemorrhage, since complete resection of this lesion is critical for the successful 




Supratentorial primitive neuroectodermal tumors (PNETs) belong to a heterogeneous 
group of undifferentiated or poorly differentiated tumors called small round blue cell 
tumors (SRBCTs)9,16) of the central nervous system (CNS), which occur predominantly 
in children or young adults.8,12) Recently, supratentorial PNETs were grouped together 
with all extracerebellar PNETs and renamed CNS PNET.11) Supratentorial PNETs are 
less common than cerebellar PNETs and account for 2-3% of all childhood brain tumors 
with a peak in the first 3 years of life.18) Preoperative neuroradiological findings vary 
and may consist of an enhanced lesion on T1- and T2-weighted magnetic resonance 
(MR) imaging or computed tomography (CT) with contrast medium, associated with 
cystic and necrotic portions, perifocal edema, or hemorrhage.4) Initiation of early and 
interdisciplinary adjuvant treatment for PNETs after complete neurosurgical resection is 
critical for the patient, since these tumors show much more aggressive behavior and the 
treatment options are poorly defined compared to infratentorial counterparts. 
 We describe a case of SRBCT obscured by a large intracerebral hemorrhage on 
preoperative imaging and hardly visible intraoperatively, which complicated the 
establishment of the diagnosis. 
 
Case Report 
A 16-year-old boy with previously unremarkable medical history was referred from a 
community hospital to our department with a progressive sensorimotor brachiofacial 
hemisyndrome on the right. His symptoms had developed mildly over 2 weeks, but he 
developed nearly complete paralysis of the right arm while playing in a field hockey 
game on the day of admission. 
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 CT and MR imaging showed a large (5.2 x 4.8 x 4.7 cm) hemorrhage in the left 
central area with signs of multistage bleeding with little perifocal edema (Fig. 1). No 
tumor was visible. CT angiography, MR angiography, and conventional angiography 
revealed no signs of vascular lesions, in particular no arteriovenous or venous 
malformations. 
 Emergency neurosurgical resection was performed within the first hours of 
admission due to his decreasing level of consciousness. During surgery the patient was 
placed in the supine position and his head was fixed with a Mayfield head holder. The 
hematoma was localized using neuro-navigation and a craniotomy was performed. After 
dura opening, the superficial part of the hematoma was visible at the level of the cortical 
surface, and the hematoma could be quickly removed by suctioning. On closer 
inspection, we discovered a small (approx. 3 x 3 mm), high cortical, superficial lesion, 
seemingly located in a subarachnoid plane between the sagittal sinus and a large cortical 
vein (Fig. 2). The lesion was soft, highly vascularized, and bright red. The lesion was 
removed gross totally. The rest of the hematoma cavity showed no macroscopic 
abnormalities. 
 Histological examination revealed a heterogeneous, pleomorphic tumor with 
unclear borders and a high proliferation index (Ki-67) of over 30% with atypic mitotic 
and apoptotic pattern (Fig. 3A, B, D). The resected lesion revealed the criteria for 
SRBCT and the diagnosis was verified by a second opinion from the Cancer Reference 
Center in Bonn and Kiel, Germany. Immunohistochemical investigations excluded 
neuronal or glial components (negative for glial fibrillary acidic protein, neurofilament 
protein, and synaptophysin) or embryonic tumors with atypical teratogenic/rhabdoid 
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fractions by molecular analyses (negative for t11/22, and no nuclear INI-1 lost). CD99 
staining for peripheral PNET was positive with a membranous pattern (Fig. 3C). 
 The postoperative course was uneventful and the hemiparesis of the right arm 
improved significantly during the first postoperative week. Postoperative CT and MR 
imaging showed complete removal of the hematoma and no signs of tumor remnant (Fig. 
4). The postoperative staging revealed negative lumbar puncture and biopsies of bone 
marrow and muscle were negative for malignant cells. Axial MR imaging of the spine 
showed a small (0.2 x 0.2 cm) single intraspinal enhanced lesion (T11) suggestive of 
leptomeningeal dissemination, which could not be confirmed by positron emission 
tomography imaging and follow-up MR imaging 3 months later. After sperm 
cryopreservation, adjuvant radiation with boost to the whole neuraxis and brain was 
initiated 4 weeks after surgery for 6 weeks followed by chemotherapy with cisplatin. 
 
Discussion 
SRBCT including CNS or peripheral PNETs are high-grade malignant cerebral tumors, 
which affect both the pediatric and adult population.12) Treatment is often challenging 
and frustrating due to the poor prognosis, and depends on many risk factors such as 
localization of the lesion and grade of staging at diagnosis.3,5) Compared to other 
embryonic malignant tumors such as medulloblastoma with better established treatment 
regimes, the optimum treatment of this rare and heterogeneous tumor group is still the 
subject of research and many clinical studies are ongoing.10,14,19,22) Today, surgery is 
recommended for the care of PNET patients (>3 years of age) followed by radiation14) 
and chemotherapy.8,20) No standards have been established, high dose chemotherapy 
with different regimes may be better before radiation in younger children.7,13) In contrast, 
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radiation directly after surgery is recommended before chemotherapy in older children 
or adults.17) 
 On this account, cases of SRBCT need to be analyzed in great detail in order to 
gain data for future treatment options. Until then, it is critical to guarantee the best 
starting position for radiation and chemotherapy by surgical resection, and therefore 
identification of this lesion as soon as possible is important. Due to the heterogeneity of 
this embryonic tumor group, neuroradiological findings are usually non-uniform and 
may hinder or delay the diagnosis.4) For example, analysis of 13 pediatric patients with 
CNS PNETs found heterogeneous neuroradiological findings whereas only 3 cases 
revealed radiological signs of hemorrhage.6) In contrast to the uncommon appearance of 
hemorrhagic areas, cystic parts and foci of calcification were more frequently found as 
described previously.1) However, in the present case, the lesion was surrounded by 
extensive intracerebral bleeding, and the clear and distinctive criteria for these tumors, 
such as cystic, necrotic, or contrast-enhanced parts,4) could not be detected on CT or 
MR imaging. The macroscopic view during surgery showed a small highly vascularized 
tumor, which could be completely resected. Although the precise pathophysiological 
mechanisms of hemorrhage into brain tumors are still under investigation, primitive 
tumors carry higher risk of bleeding than other types.21) The cause might be found in the 
dysmorphic configuration of the tumor vessels with endothelial abnormalities such as 
alteration of tight junctions, which render these lesions more hemorrhage-prone.15) 
 In this case, histological examination revealed the most likely criteria for 
peripheral PNET, based on the absence of staining against neuroepithelial antigens, and 
positive staining for CD99 in the membrane. Ewing family of tumors, especially the 
subgroup peripheral PNET and Ewing's sarcoma, usually highly express the MIC2 gene 
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product (CD99) and show chromosomal translocations such as t(11, 22)(q29; q12).2) In 
contrast, CNS PNETs are reported to be negative for both these features. In our case, 
the histological findings and extraaxial localization of the lesion strongly suggested that 
this SRBCT was a peripheral PNET rather than a CNS PNET, although no 
chromosomal translocations were detected in this tumor. 
 The present case shows that a small supratentorial, extraaxial PNET can be the 
cause of extensive acute intracerebral hemorrhage, although the tumor may not be 
detectable on preoperative MR imaging or CT. The present tumor was hidden in a small 
superficial, submeningeal pocket next to a cortical vein, so meticulous search for a 
tumorous lesion during hemorrhage evacuation is important, especially in the pediatric 
age group. Most aggressive tumor removal as soon as possible is critical to ensure the 
best start for radiation and chemotherapy in patients with SRBCT. The differential 
diagnosis of PNET should be considered in this heterogeneous tumor group with 
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Fig. 1 A–C: Preoperative computed tomography scans with axial (A), coronal (B), and 
sagittal (C) reconstruction indicating the multistage hemorrhage. D–I: Axial 
T1-weighted (D), T1-weighted with contrast medium (E), and T2-weighted (F), as well 
as sagittal (G) and coronal (H) reconstructed T1-weighted with contrast medium and 
coronal T2-weighted (I) magnetic resonance images showing the hemorrhage located 
next to the sagittal sinus and a cortical vein. Arrow indicates approximately the area of 
the tumor which was found intraoperatively. 
 
Fig. 2 Intraoperative microscope photograph showing a cortical vein (1), the tumorous 
lesion (2), and parts of the hematoma (3), with the suction (4) and bipolar devices (5). 
 
Fig. 3 A, B: Photomicrographs of the removed tumorous tissue revealing a hemorrhagic 
pleomorphic (A, arrows) tumor with atypic mitotic (B, arrows) and apoptotic pattern. 
Hematoxylin and eosin stain, original magnification x100?. C, D: CD99 staining 
showing membranous immunopositivity (C), and MIB-1 (Ki-67) index of over 30% (D). 
Arrows indicate positive cells. Original magnification x100?. 
 
Fig. 4 Postoperative computed tomography scans (A–C) and T1-weighted magnetic 
resonance images with contrast medium (D–F) with axial (A, D), coronal (B, E), and 
sagittal (C, F) reconstruction showing complete removal of the hematoma and no signs 
of tumor remnant. 
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